Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Christian Angermayer · Said 25 Jul 2025 · angermayer-0114

Quote

Commitment (own venture)

“Non-psychedelic strategic investments like inadascamine and etifoxine will either be divested, spun out via IPO, or developed exclusively in partnership with pharmaceutical companies.”
· Christian Angermayer on X: One of @atai_life's remaining non-wholly owned programs, inadascamine (RL-007)... · tweet

After inadascamine (RL-007) missed its primary endpoint in CIAS, Angermayer says atai will focus on wholly owned psychedelic programs (DMT, 5-MeO-DMT, R-MDMA, ibogaine) and sets out what happens to the non-psychedelic assets. Own-company claim (CONTROL).

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.

← Earlier · Later → · All statements